Predictive factors and outcomes for ibrutinib therapy in relapsed/refractory mantle cell lymphoma—a “real world” studyNarendranath Epperla, Timothy S. Fenske, Amanda F. Cashen et al.|Hematological Oncology|2017Cited by 68